IL277278A - Cyclopentane-based modulators of STING - Google Patents

Cyclopentane-based modulators of STING

Info

Publication number
IL277278A
IL277278A IL277278A IL27727820A IL277278A IL 277278 A IL277278 A IL 277278A IL 277278 A IL277278 A IL 277278A IL 27727820 A IL27727820 A IL 27727820A IL 277278 A IL277278 A IL 277278A
Authority
IL
Israel
Prior art keywords
sting
stimulator
cyclopentane
interferon genes
based modulators
Prior art date
Application number
IL277278A
Other languages
English (en)
Hebrew (he)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL277278A publication Critical patent/IL277278A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL277278A 2018-03-15 2020-09-10 Cyclopentane-based modulators of STING IL277278A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862643467P 2018-03-15 2018-03-15
US201862666204P 2018-05-03 2018-05-03
US201862742532P 2018-10-08 2018-10-08
US201962809990P 2019-02-25 2019-02-25
PCT/IB2019/052009 WO2019175776A1 (en) 2018-03-15 2019-03-12 Cyclopentane-based modulators of sting (stimulator of interferon genes)

Publications (1)

Publication Number Publication Date
IL277278A true IL277278A (en) 2020-10-29

Family

ID=66103038

Family Applications (1)

Application Number Title Priority Date Filing Date
IL277278A IL277278A (en) 2018-03-15 2020-09-10 Cyclopentane-based modulators of STING

Country Status (25)

Country Link
US (4) US10538542B2 (cg-RX-API-DMAC7.html)
EP (1) EP3765474B1 (cg-RX-API-DMAC7.html)
JP (1) JP7266942B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200131878A (cg-RX-API-DMAC7.html)
CN (1) CN111918871A (cg-RX-API-DMAC7.html)
AU (1) AU2019234043A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020018593A2 (cg-RX-API-DMAC7.html)
CA (1) CA3093631C (cg-RX-API-DMAC7.html)
CL (1) CL2020002352A1 (cg-RX-API-DMAC7.html)
CR (1) CR20200382A (cg-RX-API-DMAC7.html)
DO (1) DOP2020000160A (cg-RX-API-DMAC7.html)
EC (1) ECSP20057847A (cg-RX-API-DMAC7.html)
ES (1) ES2923298T3 (cg-RX-API-DMAC7.html)
IL (1) IL277278A (cg-RX-API-DMAC7.html)
MA (1) MA52012A (cg-RX-API-DMAC7.html)
MX (1) MX2020009587A (cg-RX-API-DMAC7.html)
NI (1) NI202000058A (cg-RX-API-DMAC7.html)
PE (1) PE20210412A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020551486A1 (cg-RX-API-DMAC7.html)
PY (1) PY1919127A (cg-RX-API-DMAC7.html)
RU (1) RU2020130048A (cg-RX-API-DMAC7.html)
SG (1) SG11202008102VA (cg-RX-API-DMAC7.html)
TW (1) TWI741268B (cg-RX-API-DMAC7.html)
UY (1) UY38145A (cg-RX-API-DMAC7.html)
WO (1) WO2019175776A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11203610B2 (en) 2017-12-20 2021-12-21 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
JP7037667B2 (ja) 2017-12-20 2022-03-16 インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. Stingアダプタータンパク質を活性化するホスホン酸結合を有する3’3’環状ジヌクレオチド
US10538542B2 (en) * 2018-03-15 2020-01-21 Pfizer Inc. Cyclopentane-based modulators of STING (stimulator of interferon genes)
TWI833744B (zh) 2018-04-06 2024-03-01 捷克科學院有機化學與生物化學研究所 3'3'-環二核苷酸
TW202028179A (zh) 2018-10-08 2020-08-01 美商普萊恩醫療公司 胺基酸化合物及使用方法
PH12022550709A1 (en) * 2019-09-25 2023-03-27 Pfizer Polyheterocyclic modulators of sting (stimulator of interferon genes)
US20230141284A1 (en) 2020-04-10 2023-05-11 Ono Pharmaceutical Co., Ltd. Cancer therapeutic method
EP4259642A1 (en) * 2020-12-08 2023-10-18 F. Hoffmann-La Roche AG Novel synthesis of phosphorodithioate oligonucleotides
US11964978B2 (en) * 2021-03-18 2024-04-23 Pfizer Inc. Modulators of STING (stimulator of interferon genes)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
EP3152217B1 (en) 2014-06-04 2018-08-01 GlaxoSmithKline Intellectual Property Development Limited Cyclic di-nucleotides as modulators of sting
GB201501462D0 (en) 2015-01-29 2015-03-18 Glaxosmithkline Ip Dev Ltd Novel compounds
US10538542B2 (en) * 2018-03-15 2020-01-21 Pfizer Inc. Cyclopentane-based modulators of STING (stimulator of interferon genes)

Also Published As

Publication number Publication date
ECSP20057847A (es) 2021-04-29
KR20200131878A (ko) 2020-11-24
PE20210412A1 (es) 2021-03-04
WO2019175776A1 (en) 2019-09-19
CR20200382A (es) 2020-12-10
JP7266942B2 (ja) 2023-05-01
US10538542B2 (en) 2020-01-21
MX2020009587A (es) 2020-10-05
EP3765474A1 (en) 2021-01-20
US10968242B2 (en) 2021-04-06
PH12020551486A1 (en) 2021-08-23
US20190284216A1 (en) 2019-09-19
PY1919127A (es) 2020-08-26
CA3093631A1 (en) 2019-09-19
CA3093631C (en) 2023-01-24
ES2923298T3 (es) 2022-09-26
RU2020130048A (ru) 2022-04-15
CN111918871A (zh) 2020-11-10
TWI741268B (zh) 2021-10-01
US20200102334A1 (en) 2020-04-02
CL2020002352A1 (es) 2020-12-18
MA52012A (fr) 2021-01-20
NI202000058A (es) 2021-01-08
BR112020018593A2 (pt) 2020-12-29
AU2019234043A1 (en) 2020-09-17
US20230382932A1 (en) 2023-11-30
DOP2020000160A (es) 2020-09-30
JP2021518335A (ja) 2021-08-02
SG11202008102VA (en) 2020-09-29
UY38145A (es) 2019-10-31
TW201945036A (zh) 2019-12-01
EP3765474B1 (en) 2022-06-15
RU2020130048A3 (cg-RX-API-DMAC7.html) 2022-04-15
US20210230196A1 (en) 2021-07-29

Similar Documents

Publication Publication Date Title
IL276844A (en) Interferon gene stimulator agonists and their uses
IL291650A (en) Polyheterocyclic substances and their use as sting modulators
SG11202008102VA (en) Cyclopentane-based modulators of sting (stimulator of interferon genes)
IL288868A (en) The next generation of interferon gene stimulator modulators (sting)
ZA201904311B (en) Cyclic dinucleotides as sting (stimulator of interferon genes) agonists
IL272928A (en) Cyclic dinucleotides as inducers of interferon gene modulators
ZA201908496B (en) Small molecule modulators of human sting
IL293527B2 (en) Heterocyclic compounds as modulators of stimulator of interferon genes (STING)
IL293558B2 (en) Heterocyclic compounds functional as modulators of stimulator of interferon genes (STING)
GB2587392B (en) Nerve Stimulation
SG11202106378VA (en) Modulators of hsd17b13 expression
SG11202102636UA (en) Modulators of pnpla3 expression
IL320674A (en) Garden care
IL292155A (en) Stimulation of neural plasticity
GB201709959D0 (en) Small molecule modulators of human STING
IL285333A (en) Modulators of malat1 expression
IL280531A (en) Methods for gene therapy to control organ function
IL276007A (en) Modulators for dnm2 expression
IL279685A (en) Gene therapy
IL283072A (en) Modulators of IRF5 expression
IL277847A (en) Modulators of EZH2 expression
IL290772A (en) Monocyclic substances and their use as promoters of expression of interferon genes
IL290771A (en) Bicyclic substances and their use as promoters of interferon gene expression
GB201701968D0 (en) Gene therapy
IL274231A (en) Modulators of ENAC expression